AUROBINDO PHARMA LTD FDA Approval ANDA 213657

ANDA 213657

AUROBINDO PHARMA LTD

FDA Drug Application

Application #213657

Application Sponsors

ANDA 213657AUROBINDO PHARMA LTD

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORALEQ 2MG BASE0ALBUTEROL SULFATEALBUTEROL SULFATE
002TABLET;ORALEQ 4MG BASE0ALBUTEROL SULFATEALBUTEROL SULFATE

FDA Submissions

UNKNOWN; ORIG1AP2020-05-14STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

AUROBINDO PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213657
            [companyName] => AUROBINDO PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"ALBUTEROL SULFATE","activeIngredients":"ALBUTEROL SULFATE","strength":"EQ 2MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ALBUTEROL SULFATE","activeIngredients":"ALBUTEROL SULFATE","strength":"EQ 4MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/14\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-05-14
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.